Finance

Lists
WOCKPHARMA:NSE
Wockhardt Ltd
1 961,30 INR
-1,25%
(-24,80) 1D
15-окт., 14:40:16 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for WOCKPHARMA...
Open
1 988,00 INR
High
1 988,00 INR
Low
1 946,60 INR
Mkt. cap
319,78 млд
Avg. vol.
1,18 млн
Volume
343,46 миң
P/E ratio
77,91
52-wk high
2 422,30 INR
52-wk low
1 086,70 INR
EPS
25,17 INR
Shares outstanding
110,69 млн
No. of employees
3 миң
Open
1 988,00 INR
High
1 988,00 INR
Low
1 946,60 INR
Mkt. cap
319,78 млд
Avg. vol.
1,18 млн
Volume
343,46 миң
P/E ratio
77,91
52-wk high
2 422,30 INR
52-wk low
1 086,70 INR
EPS
25,17 INR
Shares outstanding
110,69 млн
No. of employees
3 миң
News stories
From web sources and news partners
Profile
Wockhardt is an Indian pharmaceutical and biotechnology company headquartered in Mumbai, India. It produces formulations, biopharmaceuticals, nutrition products, vaccines and active pharmaceutical ingredients. The company has manufacturing plants in India, the UK, Ireland, France and US, and subsidiaries in US, UK, Ireland and France. Wikipedia
About Wockhardt Ltd
CEOMurtaza Khorakiwala
Employees2,56 миң
Founded1967
Headquarters-
SectorPharmaceutical industry
Last report
2026-ж., 10-авг.
Fiscal period
Q1 2027
- / -
Revenue / Est. (INR)
9,29 млд / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
7,82 млд
8,88 млд
10,54 млд
9,29 млд
Cost of goods sold
2,33 млд
3,17 млд
4,03 млд
3,20 млд
Cost of revenue
2,33 млд
3,17 млд
4,03 млд
3,20 млд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,86 млд
1,81 млд
1,90 млд
2,03 млд
Operating expense
4,42 млд
4,63 млд
4,19 млд
4,76 млд
Total operating expenses
6,75 млд
7,80 млд
8,22 млд
7,96 млд
Operating income
1,07 млд
1,08 млд
2,32 млд
1,33 млд
Other non operating income
210,00 млн
250,00 млн
-710,00 млн
310,00 млн
EBT including unusual items
910,00 млн
670,00 млн
1,89 млд
1,16 млд
EBT excluding unusual items
910,00 млн
770,00 млн
1,52 млд
1,16 млд
Income tax expense
90,00 млн
60,00 млн
250,00 млн
90,00 млн
Effective tax rate
9,89%
8,96%
13,23%
7,76%
Other operating expenses
2,03 млд
2,17 млд
1,76 млд
2,18 млд
Net income
780,00 млн
590,00 млн
1,66 млд
1,06 млд
Net profit margin
9,97%
6,64%
15,75%
11,41%
Earnings per share
-
-
-
-
Interest and investment income
-
-
70,00 млн
-
Interest expense
-550,00 млн
-600,00 млн
-450,00 млн
-520,00 млн
Net interest expenses
-550,00 млн
-600,00 млн
-380,00 млн
-520,00 млн
Depreciation and amortization charges
530,00 млн
650,00 млн
530,00 млн
550,00 млн
EBITDA
1,62 млд
1,47 млд
2,74 млд
1,74 млд
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору